We found that cDC1 numbers are increased in tumors from hsBCL9z96-treated CT26 tumor-bearing mice, as well as MC38 tumor-bearing Bcl9/Bcl9l deficiency mice (Fig. 6b). This evidence concerns the gene BCL9L and neoplasm.